Uric acid and dementia in community-dwelling older persons

Dementia and Geriatric Cognitive Disorders

Volumn 27, Issue 4, 2009, Pages 382-389

  Ruggiero, Carmelinda ^a,i   Cherubini, Antonio ^a   Lauretani, Fulvio ^b   Bandinelli, Stefania ^c   Maggio, Marcello ^d   Di Iorio, Angelo ^e   Zuliani, Giovanni ^f   Dragonas, Charalampos ^g   Senin, Umberto ^a   Ferrucci, Luigi ^h  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Tuscany Regional Health Agency   (Italy)

^c ASF Geriatric Rehabilitation   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

^f UNIVERSITY OF FERRARA   (Italy)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h NATIONAL INSTITUTE ON AGING   (United States)

ⁱ SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Aging; Dementia; Inflammation; Risk; Uric acid

Indexed keywords

URIC ACID;

AGED; AGING; ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

AGED; ALCOHOL DRINKING; C-REACTIVE PROTEIN; CHOLESTEROL; DEMENTIA; ENERGY INTAKE; FEMALE; HUMANS; INTERLEUKIN-6; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; SOCIOECONOMIC FACTORS; URIC ACID; VITAMIN E;

EID: 63349098758     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210040     Document Type: Article

References (43)

1. Flirski M, Sobow T: Biochemical markers and risk factors of Alzheimer's disease. Curr Alzheimer Res 2005; 2: 47-64.
2. Lahiri DK, Maloney B, Basha MR, Ge YW, Zawia NH: How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the 'LEARn' model (latent early-life associated regulation) may explain the triggering of AD. Curr Alzheimer Res 2007; 4:219-228.
3. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N: Oxidative damage in Alzheimer's. Nature 1996; 382: 120-121.
4. Neuroinflammation Working Group: Inflammation and Alzheimer's disease. Neurobiol. Aging 2000; 21: 383-421.
5. Wu XW, Muzny DM, Lee CC, Caskey CT: Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 1992; 34: 78-84.
6. Ames BN, Cathcart R, Schwiers E, Hochstein P: Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Nat l Acad Sci USA 1981; 78: 6858-6862.
7. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA: Uric acid and oxidative stress. Curr Pharm Des 2005; 11 : 4145 - 4151.
8. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Sha m i m W, Kemp M, Segal R, Osterziel KJ, Leyva F, Hetzer R, Ponikowski P, Coats AJ: Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003; 107: 1991-1997.
9. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L: Uric acid and inflammator y markers. Eur Heart J 2006; 27: 1174 -1181.
10. Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R: Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure. Circulation 2002; 105: 2619-2624.
11. Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J: A unifying pathway for essential hypertension. Am J Hypertens 2005; 18:431-440.
12. Ford ES, Li C, Cook S, Choi HK: Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007; 115:2526-2532.
13. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41:1183 -1190.
14. Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, Kakafika A, Gossios T, Krikis N, Moschou I, Xochellis M, Athyros VG: Serum uric acid as an independent predictor of early death after acute stroke. Circ J 2007; 71: 1120-1127.
15. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283:2404-2410.
16. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT: Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004; 164:1546-1551.
17. Meisinger C, Koenig W, Baumert J, Döring A: Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008; 28:1186-1192.
18. Schretlen DJ, Inscore AB, Jinnah HA, Rao V, Gordon B, Pearlson GD: Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology 2007; 21:136-140.
19. Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris TB, Guralnik JM: Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 2000; 48: 1618-162 5.
20. Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F: Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centers. Int J Epidemiol 1997; 26: 152-160.
21. Salvini S: A food composition database for epidemiological studies in Italy. Cancer 1997; 114:299-300
22. Guralnik JM, Fried LP, Simonsick EM, Kasper JD, Lafferty ME: The Women's Health and Aging Study: health and social characteristics of older women with disability. Bethesda, National Institute of Aging, 1995.
23. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
24. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease. Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
25. McDermott MM, Guralnik JM, Albay M, Bandinelli S, Miniati B, Ferrucci L: Impairments of muscles and nerves associated with peripheral arterial disease and their relationship with lower extremity functioning: the InCHIANTI Study. J Am Geriatr Soc 2004; 52: 405-410.
26. Cherubini A, Martin A, Andres-Lacueva C, Di Iorio A, Lamponi M, Mecocci P, Bartali B, Corsi A, Senin U, Ferrucci L: Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study. Neurobiol Aging 2005; 26:987-994.
27. Richmond W: Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973; 19: 1350-1356.
28. Cherubini A, Andres-Lacueva C, Martin A, Lauretani F, Di Iorio A, Bartali B, Corsi A, Bandinelli S, Mattson MP, Ferrucci L: Low plasma n-3 fatty acids and dementia in older subjects: the InCHIANTI study. J Gerontol Med Sci 2007; 62:1120-1126.
29. Wechsler D: Wechsler Memory Scale-Revised Manual. San Antonio, Psychological Corporation, 1987.
30. Carlesimo GA, Caltagirone C, Gainotti G: The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Bat ter y. Eur Neurol 1996; 36: 378-384.
31. Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G: Three clinical tests of long-term verbal memory. Calibration on normal subjects. Arch Psicol Neurol Psichiatria 1986; 47: 278-296.
32. Stetten D Jr, Hearon JZ: Intellectual level measured by army classification battery and serum uric acid concentration. Science 1959; 129:1737.
33. Dunn JP, Brooks GW, Mausner J, Rodnan GP, Cobb S: Social class gradient of serum uric acid levels in males. JAMA 1963; 185: 431-436.
34. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P: Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 2003; 24: 915 - 919.
35. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG: Uric acid and serum anti-oxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000; 148 : 131-139.
36. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM: Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 2005; 58: 797-800.
37. Weisskopf MG, O'Reilly E, Chen H, Schwarz-schild MA, Ascherio A: Plasma urate and risk of Parkinson's disease. Am J Epidemiol 2007; 166:561-567.
38. Shi Y, Evans JE, Rock KL: Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516 -521.
39. Ruggiero C, Cherubi ni A, Miller E 3rd, Maggio M, Najjar SS, Lauretani F, Bandinelli S, Senin U, Ferrucci L: Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol 2007; 100: 115-121.
40. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M: Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005; 25:1038- 1044.
41. Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E, Vettoretti S, Bezante GP, Del Sette M, Deferrari G, Pontremoli R: Serum uric acid and target organ damage in primary hypertension. Hypertension 2005; 45:991-996.
42. Yu KH, Luo SF, Tsai WP, Huang YY: Intermittent elevation of serum urate and 24hour urinary uric acid excretion. Rheumatology (Oxford) 2004; 43: 1541-1545.
43. Nakanishi N, Yoshida H, Nakamura K, Suzuki K, Tatara K : Predictors for developme nt of hyperuricemia: an 8-year longitudinal study in middle-aged Japanese men. Metabolism 2001; 50:621-626.